Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Julian Levell is active.

Publication


Featured researches published by Julian Levell.


Archive | 1997

Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

Yong Mi Choi-Sledeski; Heinz W. Pauls; Jeffrey N. Barton; William R. Ewing; Daniel M. Green; Michael R. Becker; Yong Gong; Julian Levell


Bioorganic & Medicinal Chemistry Letters | 2005

Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase

Corey R. Hopkins; Mark Czekaj; Steven S. Kaye; Zhongli Gao; James Pribish; Henry W. Pauls; Guyan Liang; Keith Sides; Dona Cramer; Jennifer Cairns; Yongyi Luo; Heng Keang Lim; Roy J. Vaz; Sam Rebello; Sebastian Maignan; Alain Dupuy; Magali Mathieu; Julian Levell


Archive | 2001

1-Aroyl-piperidinyl benzamidines

Heinz W. Pauls; Yong Gong; Julian Levell; Peter Charles Astles; Paul Robert Eastwood


Bioorganic & Medicinal Chemistry | 2005

Structure based design of 4-(3-aminomethylphenyl)piperidinyl-1-amides: novel, potent, selective, and orally bioavailable inhibitors of βII tryptase

Julian Levell; Peter Charles Astles; Paul Robert Eastwood; Jennifer Cairns; Olivier Houille; Suzanne Aldous; Gregory H. Merriman; Brian Whiteley; James Pribish; Mark Czekaj; Guyan Liang; Sébastien Maignan; Jean-Pierre Guilloteau; Alain Dupuy; Jane Davidson; Trevor K.P. Harrison; Andrew David Morley; Simon Watson; Garry Fenton; Clive McCarthy; Joseph Romano; Rose Mappilakunnel Mathew; Darren Engers; Michael Gardyan; Keith Sides; Jennifer Kwong; Joseph Tsay; Sam Rebello; Liduo Shen; Jie Wang


Archive | 2005

[4-(5-Aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase

Zhongli Gao; Larry Davis; Julian Levell; Mark Czekaj; Adam W. Sledeski; El-Bdaoui Haddad


Archive | 1999

Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

Yong Mi Choi-Sledeski; Heinz W. Pauls; Jeffrey N. Barton; William R. Ewing; Daniel M. Green; Michael R. Becker; Yong Gong; Julian Levell


Bioorganic & Medicinal Chemistry Letters | 2004

Design of bivalent ligands using hydrogen bond linkers: synthesis and evaluation of inhibitors for human β-tryptase

Roy J. Vaz; Zhongli Gao; James Pribish; Xin Chen; Julian Levell; Larry Davis; Eva Albert; Maurice Brollo; Antonio Ugolini; Dona Cramer; Jennifer Cairns; Keith Sides; Feng Liu; Jennifer Kwong; Jiesheng Kang; Sam Rebello; Michael Elliot; Heng-Keang Lim; Vinolia Chellaraj; Robert W. Singleton; Yi Li


Archive | 2009

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2-yl)-methanone hydrochloride as an inhibitor of mast cell tryptase

Zhongli Gao; Larry Davis; Julian Levell; Mark Czekaj; Adam W. Sledeski


Archive | 2005

Substituted propane phosphinic acid derivatives

Yong Mi Choi-Sledeski; Julian Levell; Gregory Bernard Poli; Mark Czekaj; Alan John Collis; Roy J. Vaz


Archive | 2001

1-aroyl-piperidinyl benzamidines 1-aroyl-piperidinyl benzamidines

Heinz W. Pauls; Paul Robert Eastwood; Peter Charles Astles; Yong Gong; Julian Levell

Collaboration


Dive into the Julian Levell's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge